Global Blood Therapeutics

YTD

ALL

Why Robinhood?

You can watch GBT and buy or sell other stocks, ETFs, and their options commission-free!

About GBT

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases.

CEO

Bert Bruce

CEOBert Bruce

Employees

—

Employees—

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2011

Founded2011

Employees

—

Employees—

GBT Key Statistics

Market cap

4.62B

Market cap4.62B

Price-Earnings ratio

-13.70

Price-Earnings ratio-13.70

Dividend yield

—

Dividend yield—

Average volume

2.06M

Average volume2.06M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$73.02

52 Week high$73.02

52 Week low

$21.65

52 Week low$21.65

People also own

Based on the portfolios of people who own GBT. This list is generated using Robinhood data, and it’s not a recommendation.